Quantcast

moffitt

0

Newly discovered regulatory mechanism of myeloid cells in cancer

February 19, 2013
biomedical

Researchers at the Moffitt Cancer Center have found a potential mechanism by which immune suppressive myeloid-derived suppressor cells can prevent immune …Click Here to Read More

0

Improving the development of new cancer models using advanced biomedical imaging method

December 31, 2012
biomedical

Scientists at the University of Arizona Cancer Center and the Moffitt Cancer Center, led by Dr. Robert Gillies, have demonstrated …Click Here to Read More

0

Moffitt Cancer Researchers Embark on Personalized Clinical Trial for Squamous Cell Lung Cancer

October 30, 2012
biotech

Working with an international team of scientists, researchers at Moffitt Cancer Center have started a first-of-its-kind clinical trial for patients …Click Here to Read More

0

Two-Drug Synergy to Treat Drug-Resistant Chronic Myeloid Leukemia

October 26, 2012
biomedical

An interdisciplinary team of researchers has dissected a case of synergy in drug-resistant chronic myeloid leukemia to understand the mechanism …Click Here to Read More

0

Moffitt Researchers Identify Unique Immune Gene Signature across Thousands of Patients’ Solid Tumors

October 25, 2012
biotech

Moffitt Cancer Center researchers have discovered a unique immune gene signature that can predict the presence of microscopic lymph node-like …Click Here to Read More

0

Peripheral Blood Stem Cell Transplants from Unrelated Donors Associated with Higher Rates of Chronic Graft-Versus-Host-Disease

October 19, 2012
biomedical

Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors compares two-year survival probabilities for patients transplanted with peripheral blood stem …Click Here to Read More

0

Moffitt Cancer Center Researchers Study ‘ACT TIL’ Approach to Treating Metastatic Melanoma

October 18, 2012
biomedical

by +Richard Holbrooke – Moffitt Cancer Center researchers have carried out a clinical trial in which patients with metastatic melanoma …Click Here to Read More

0

DNA Damage Response Network Integrates with Other Cell Activities, Opens Door to New Cancer Therapies

October 16, 2012
biotech

by +Mike Poller – Researchers at Tampa’s Moffitt Cancer Center and colleagues at the University of South Florida have discovered …Click Here to Read More

1

USF online service to match eligible patients & clinical trials

October 5, 2012
clinical

USF Health and EmergingMed have launched a Clinical Trials Matching Service that offers patients, caregivers and healthcare professionals a personalized, …Click Here to Read More

0

Modulation Therapeutics, founded by USF/Moffitt Cancer Center researchers, receives grant

September 6, 2012
biotech

Modulation Therapeutics, Inc. has been awarded a $156,202 Phase 1 SBIR grant from the National Cancer Institute. Modulation Therapeutics is …Click Here to Read More